Skip to main content
SpringerLink
Log in

Patientenselektion und Kriterien für die Verlaufskontrolle

Antikörper bei schwerem Asthma - ein Update

Treatment update of severe asthma with antibodies

  • FB_Schwerpunkt-Übersicht
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Author information

Authors and Affiliations

  1. Med. Klinik III, Kreiskliniken Reutlingen, Steinenberg Straße 31, 72764, Reutlingen, Deutschland

    Adrian Gillissen

Authors
  1. Adrian Gillissen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adrian Gillissen.

Ethics declarations

Honorierte Vorträge: AstraZeneca, Berlin-Chemie, Novartis, Chiesi, Pohl-Boskamp, Esanum, GNS; Advisory Boards: AstraZeneca, Chiesi, MSD Sharp & Dohme; Reisekostenübernahmen: AstraZeneca, Berlin-Chemie (Angaben für die letzten 5 Jahren)

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gillissen, A. Antikörper bei schwerem Asthma - ein Update. MMW - Fortschritte der Medizin 164, 44–47 (2022). https://doi.org/10.1007/s15006-022-1990-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-022-1990-9

Keywords:

Search

Navigation